B
New in the British Journal of Cancer: post hoc analysis of METIMMOX - high TMB or BRAF-V600E may identify nivolumab responders in MSS metastatic CRC.
Hypothesis-generating,
PFS only,
prognostic vs. predictive unresolved.
But a signal worth pursuing. 🧬
"This is not the AI we were promised." Prof Michael Wooldridge warns the breakneck AI race risks a Hindenburg-style catastrophe.
​
In 2026, IPOs/valuations seem to trump safety. Time to rebalance incentives before markets brutally enforce it.
28M Medicare patients, 18 years, PM2.5 → Alzheimer's risk. Effect "direct"—not through hypertension or stroke. Interesting. But ZIP-code SES adjustment + ICD-code AD diagnosis = residual confounding still very much alive. https://bit.ly/3MOu1nS
Moltbook: 1.5M AI agents posting on a social network where humans just watch. Karpathy calls it "sci-fi takeoff-adjacent." Real tech capability or elaborate performance art? Probably both. Worth watching either way. 🦞
RE: https://med-mastodon.com/@ben_geisler/115746748711190562
Publication update: "50 Studies Every Hospitalist Should Know" is now available as a Kindle ebook on Amazon!
After extensive collaboration across continents and countless editorial rounds, it's gratifying to see this resource finally accessible to hospitalists. Print edition forthcoming.
https://www.amazon.com/Studies-Every-Hospitalist-Should-Doctor-ebook/dp/B0GHSNKVKB/